Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.22.2.2
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share

 

 

Three months ended
September 30, 2022

 

 

Nine months ended
September 30, 2022

 

 

 

Voting common stock

 

 

Non-voting common stock

 

 

Voting common stock

 

 

Non-voting common stock

 

Basic net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

Numerator

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of undistributed losses attributable to common stockholders

 

$

(10,083

)

 

$

(1,344

)

 

$

(32,526

)

 

$

(4,757

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares used in basic per share computation

 

 

25,601,495

 

 

 

3,412,500

 

 

 

25,287,436

 

 

 

3,698,581

 

Net loss per share, basic

 

$

(0.39

)

 

$

(0.39

)

 

$

(1.29

)

 

$

(1.29

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

Numerator

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of undistributed losses for basic computation

 

$

(10,083

)

 

$

(1,344

)

 

$

(32,526

)

 

$

(4,757

)

Reallocation of undistributed losses as a result of conversion of
     non-voting to voting common shares

 

 

(1,344

)

 

 

 

 

 

(4,757

)

 

 

 

Allocation of undistributed losses

 

$

(11,427

)

 

$

(1,344

)

 

$

(37,283

)

 

$

(4,757

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares used in basic per share computation

 

 

25,601,495

 

 

 

3,412,500

 

 

 

25,287,436

 

 

 

3,698,581

 

Add: conversion of non-voting to voting common shares outstanding

 

 

3,412,500

 

 

 

 

 

 

3,698,581

 

 

 

 

Weighted average number of shares used in diluted per share computation

 

 

29,013,995

 

 

 

3,412,500

 

 

 

28,986,017

 

 

 

3,698,581

 

Net loss per share, diluted

 

$

(0.39

)

 

$

(0.39

)

 

$

(1.29

)

 

$

(1.29

)

 

 

 

 

Three months ended
September 30, 2021

 

 

Nine months ended
September 30, 2021

 

 

 

Voting common stock

 

 

Non-voting common stock

 

 

Voting common stock

 

 

Non-voting common stock

 

Basic net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

Numerator

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of undistributed losses attributable to common stockholders

 

$

(9,631

)

 

$

(1,929

)

 

$

(26,651

)

 

$

(5,750

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares used in basic per share computation

 

 

21,534,342

 

 

 

4,312,500

 

 

 

20,389,242

 

 

 

4,398,437

 

Net loss per share, basic

 

$

(0.45

)

 

$

(0.45

)

 

$

(1.31

)

 

$

(1.31

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted net loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

Numerator

 

 

 

 

 

 

 

 

 

 

 

 

Allocation of undistributed losses for basic computation

 

$

(9,631

)

 

$

(1,929

)

 

$

(26,651

)

 

$

(5,750

)

Reallocation of undistributed losses as a result of conversion of
     non-voting to voting common shares

 

 

(1,929

)

 

 

 

 

 

(5,750

)

 

 

 

Allocation of undistributed losses

 

$

(11,560

)

 

$

(1,929

)

 

$

(32,401

)

 

$

(5,750

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares used in basic per share computation

 

 

21,534,342

 

 

 

4,312,500

 

 

 

20,389,242

 

 

 

4,398,437

 

Add: conversion of non-voting to voting common shares outstanding

 

 

4,312,500

 

 

 

 

 

 

4,398,437

 

 

 

 

Weighted average number of shares used in diluted per share computation

 

 

25,846,842

 

 

 

4,312,500

 

 

 

24,787,679

 

 

 

4,398,437

 

Net loss per share, diluted

 

$

(0.45

)

 

$

(0.45

)

 

$

(1.31

)

 

$

(1.31

)

Schedule of Antidilutive Shares Excluded from Calculation of Diluted Net Loss Per Share he following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share, as their effect is anti-dilutive:

 

 

As of September 30,

 

 

 

2022

 

 

2021

 

Stock options to purchase common stock

 

 

6,084,284

 

 

 

4,038,981

 

Non-vested common stock

 

 

 

 

 

2,110

 

 

 

 

6,084,284

 

 

 

4,041,091